ஏச் மைக்கேல் ஷெப்பர்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஏச் மைக்கேல் ஷெப்பர்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஏச் மைக்கேல் ஷெப்பர்ட் Today - Breaking & Trending Today

Enosi Life Sciences Featured on America's Next Investment


Enosi Life Sciences Featured on America’s Next Investment
Company’s appearance comes concurrently with its Regulation D, 506c Offering
May 25, 2021 08:00 ET
| Source:
Enosi Life Sciences
Enosi Life Sciences
Enosi” or the “
Company”), a drug research and development company focused on providing industry-leading therapeutics for autoimmune disease, cancer, and acute inflammation, today shared its appearance on “America’s Next Investment” a national TV series focused to help companies raise capital through equity crowdfunding.
Enosi’s 60-second segment will air on CNBC, FOX Business, Bloomberg, and other national programs where viewers should check their local listings to find the appropriate dates and times. The corporate feature details Enosi’s formation and leadership, business objectives, and novel approach to developing therapies that address cancer, autoimmune disease, and inflammatory conditions ....

United States , Marc Feldmann , Tom Becker , H Michael Shepard , Enosi Life Sciences Corp , Life Sciences Corp , Enosi Life Sciences , Life Sciences , Professor Sir Marc Feldmann , Executive Chairman , ஒன்றுபட்டது மாநிலங்களில் , மார்க் பெல்ட்மண்ன , டோம் பெக்கர் , ஏச் மைக்கேல் ஷெப்பர்ட் , வாழ்க்கை அறிவியல் கார்ப் , வாழ்க்கை அறிவியல் , ப்ரொஃபெஸர் ஐயா மார்க் பெல்ட்மண்ன , நிர்வாகி தலைவர் ,

A single approach to creating cancer and autoimmune disease therapeutics


Dr H. Michael Shepard, CEO and CSO of Enosi Life Sciences, discusses the similarities between cancer and autoimmune diseases, highlighting how this knowledge could be used to enhance treatments.
The progression of cancer and autoimmune diseases are both characterised by intense inflammation and both diseases recruit immune cells to quell the escalating inflammation. In cancer, the recruitment of these cells, primarily regulatory (suppressor) T cells, attempt to resolve the ongoing inflammation with the result of turning down anticancer immunity. In autoimmune diseases, the constant stimulation of inflammation (immune reaction against the body’s own tissues) overwhelms the regulatory T cells. In both diseases other immune cells can also suppress immunity, with similar results as regulatory T cells. Furthermore, the biochemical pathways that regulate immune cell function are the same in both diseases. ....

H Michael Shepard , Board Member Of Enosi Life Sciences , World Health Organization , Lasker Debakey Clinical Medical Research , Us National Cancer Institute , Enosi Life Sciences , Harvard Medical School Warren Alpert Prize , Cancer Institute , Cancer Genome Atlas , Chief Executive Officer , Chief Scientific Officer , Board Member , Enosi Life , Debakey Clinical Medical Research , Cancer Sites , Cancer Stat Facts , Growth Factor , Nature Biomedical , ஏச் மைக்கேல் ஷெப்பர்ட் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , லாஸ்கர் டெபாகெய் மருத்துவ மருத்துவ ஆராய்ச்சி , எங்களுக்கு தேசிய புற்றுநோய் நிறுவனம் , ஹார்வர்ட் மருத்துவ பள்ளி வாரன் ஆல்பர்ட் ப்ரைஸ் , புற்றுநோய் நிறுவனம் , புற்றுநோய் மரபணு அட்லஸ் , தலைமை நிர்வாகி அதிகாரி ,